T2 Biosystems, Inc. Quarterly Operating Income (Loss) in USD from Q1 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
T2 Biosystems, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2013 to Q2 2024.
  • T2 Biosystems, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$9.58M, a 26.6% increase year-over-year.
  • T2 Biosystems, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$45.1M, a 13.4% increase year-over-year.
  • T2 Biosystems, Inc. annual Operating Income (Loss) for 2023 was -$49.7M, a 10% increase from 2022.
  • T2 Biosystems, Inc. annual Operating Income (Loss) for 2022 was -$55.2M, a 28.4% decline from 2021.
  • T2 Biosystems, Inc. annual Operating Income (Loss) for 2021 was -$43M, a 3.91% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$45.1M -$9.58M +$3.48M +26.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$48.6M -$12.6M +$1.09M +7.94% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 -$49.7M -$9.32M +$201K +2.11% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 -$49.9M -$13.6M +$2.19M +13.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-15
Q2 2023 -$52.1M -$13.1M +$1.97M +13.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$54M -$13.7M +$1.17M +7.88% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 -$55.2M -$9.52M +$759K +7.38% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$56M -$15.8M -$3.59M -29.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-15
Q2 2022 -$52.4M -$15M -$4.24M -39.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$48.1M -$14.9M -$5.16M -53.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-22
Q4 2021 -$43M -$10.3M -$1.96M -23.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$41M -$12.2M -$1.58M -14.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$39.4M -$10.8M -$1.94M -22% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-16
Q1 2021 -$37.5M -$9.7M +$3.86M +28.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$41.4M -$8.32M +$4.05M +32.7% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-23
Q3 2020 -$45.4M -$10.6M +$1.71M +13.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$47.1M -$8.84M +$4.95M +35.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$52.1M -$13.6M -$2K -0.02% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$52.1M -$12.4M +$1.23M +9.03% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-16
Q3 2019 -$53.3M -$12.3M -$3.17M -34.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$50.1M -$13.8M -$2.9M -26.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 -$47.2M -$13.6M -$2.12M -18.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$45.1M -$13.6M +$772K +5.37% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 -$45.9M -$9.17M +$3.26M +26.2% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-16
Q2 2018 -$49.1M -$10.9M +$3.02M +21.7% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-16
Q1 2018 -$52.1M -$11.4M +$1.71M +13% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-16
Q4 2017 -$53.9M -$14.4M -$1.46M -11.3% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-14
Q3 2017 -$52.4M -$12.4M -$492K -4.12% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-14
Q2 2017 -$51.9M -$13.9M -$601K -4.52% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-14
Q1 2017 -$51.3M -$13.1M -$422K -3.32% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-14
Q4 2016 -$50.9M -$12.9M -$1.36M -11.8% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-19
Q3 2016 -$49.5M -$11.9M -$780K -6.99% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-19
Q2 2016 -$48.7M -$13.3M -$2.78M -26.4% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-19
Q1 2016 -$46M -$12.7M -$2.57M -25.4% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-19
Q4 2015 -$43.4M -$11.5M -$2.71M -30.6% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-15
Q3 2015 -$40.7M -$11.2M -$3.38M -43.4% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-15
Q2 2015 -$37.3M -$10.5M -$3.38M -47.2% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-15
Q1 2015 -$33.9M -$10.1M -$3.24M -46.9% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-15
Q4 2014 -$30.7M -$8.84M -$3.2M -56.7% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-09
Q3 2014 -$27.5M -$7.79M -$3.25M -71.4% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-09
Q2 2014 -$24.2M -$7.15M -$2.24M -45.6% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-09
Q1 2014 -$22M -$6.91M -$2.31M -50.2% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-09
Q4 2013 -$19.7M -$5.64M Oct 1, 2013 Dec 31, 2013 10-K 2015-03-04
Q3 2013 -$4.54M Jul 1, 2013 Sep 30, 2013 10-K 2015-03-04
Q2 2013 -$4.91M Apr 1, 2013 Jun 30, 2013 10-K 2015-03-04
Q1 2013 -$4.6M Jan 1, 2013 Mar 31, 2013 10-K 2015-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.